Vicente Escudero Vilaplana,Jorge Huerta Aragonés,Cecilia M Fernández-Llamazares et al.
Vicente Escudero Vilaplana et al.
Very little has been published on the use of romiplostim to treat primary immune thrombocytopenia (ITP), refractory to previous treatments, in children. The objective of this study was to determine its efficacy and safety in pediatric patie...
Population pharmacokinetics of native Escherichia coli asparaginase [0.03%]
原生大肠埃希氏杆菌天冬酰胺酶的群体药代动力学研究
Stephan Borghorst,Rob Pieters,Hans-Juergen Kuehnel et al.
Stephan Borghorst et al.
The main aim of this analysis was to characterize the population pharmacokinetics of native Escherichia coli asparaginase (ASNase medac) in pediatric patients with previously untreated acute lymphoblastic leukemia. Secondary objective was t...
Iron deficiency anemia in children presenting with lymphoreticular malignancies and the effect of induction therapy [0.03%]
儿童因淋巴造血系统恶性肿瘤导致的缺铁性贫血及其诱导治疗的影响
Bhanu Kiran Bhakhri,Pankaj C Vaidya,Amita Trehan et al.
Bhanu Kiran Bhakhri et al.
There is scant information regarding iron deficiency in children with malignant disorders. Serum iron status of children with lymphoreticular malignancies (LRMs) at onset and at the end of induction therapy, compared to the normal populatio...
Feryal Gun,Basak Erginel,Aysegul Unüvar et al.
Feryal Gun et al.
Primary mediastinal malignancies are rare tumors and can originate from any mediastinal organ or tissue such as thymic, neurogenic, lymphatic, germinal, or mesenchymal. The authors reviewed all cases of primary pediatric mediastinal masses ...
ALL-BFM 95 treatment in Turkish children with acute lymphoblastic leukemia--experience of a single center [0.03%]
土耳其儿童急性淋巴细胞白血病患儿ALL-BFM95治疗的单中心经验研究
Ulker Kocak,Turkiz Gursel,Zuhre Kaya et al.
Ulker Kocak et al.
Little is known about the likelihood of curing children with high-dose chemotherapy regimens for treatment of childhood acute lymphoblastic leukemia (ALL) in Turkey. The authors here report their 13 years' experience with original ALL-BFM (...
The Cameroon 2008 Burkitt lymphoma protocol: improved event-free survival with treatment adapted to disease stage and the response to induction therapy [0.03%]
喀麦隆伯基特淋巴瘤2008年治疗方案：根据疾病分期和诱导治疗的效果调整治疗可改善无事件生存期
P B Hesseling,E Njume,F Kouya et al.
P B Hesseling et al.
Treatment of endemic Burkitt lymphoma (BL) with cyclophosphamide (CPM) and intrathecal methotrexate (IT MTX) can cure 50% of patients. In this study, induction therapy with CPM and IT MTX was followed by consolidation chemotherapy adapted f...
Pediatric non-Hodgkin lymphoma: a retrospective 14-year experience with Berlin-Frankfurt-Münster (BFM) protocols from a tertiary care hospital in Serbia [0.03%]
塞尔维亚一家三级护理医院儿科非霍奇金淋巴瘤的回顾性研究：14年柏林-法兰克福-慕尼黑(BFM)方案治疗经验
Lidija Dokmanovic,Nada Krstovski,Dragan Vukanic et al.
Lidija Dokmanovic et al.
Use of current intensive chemotherapy protocols in pediatric non-Hodgkin lymphoma (NHL) in high-income countries resulted in event-free survival (EFS) rates ranging from 80 to 90%. The results are inferior in less privileged countries with ...
Should we treat children with Down syndrome and leukemia in the developing world? [0.03%]
我们应该为发展中国家患有唐氏综合症和白血病的儿童提供治疗吗？
Vikas Dua,Satya Prakash Yadav,Anupam Sachdeva
Vikas Dua
Early-onset hemophagocytic lymphohistiocytosis after the start of chemotherapy for advanced neuroblastoma [0.03%]
化疗后早期发生的噬血细胞综合征并发神经母细胞瘤晚期住院患者的病情恶化
Shinji Kounami,Keiko Nakayama,Megumi Yoshiyama et al.
Shinji Kounami et al.
The authors report the clinical course of a 3-year-old boy with stage 4 neuroblastoma (NB) complicated by hemophagocytic lymphohistiocytosis (HLH) immediately after the start of chemotherapy. The NB responded very well to the chemotherapy, ...